Thermo Fisher Scientific’s new tumoroid culture medium kit is designed to help cancer researchers better model the disease.
Eurofins Genomics Blue Heron’s novel mRNA synthesis service is designed for customizable applications.
Experts outline the benefits of single-use consumables relative to traditional approaches.
If we view a change opposite of one’s interest as antithetical to innovation, we risk losing sight of our ultimate goal.
Donaldson Company’s €136 million (US$148 million) acquisition of Univercells is designed to broaden its portfolio of biomanufacturing solutions.
Mason Ailstock, CEO of the Rowen Foundation, discusses incubators and their potential to promote innovation.
FDA approved Pfizer’s once-weekly human growth hormone analog for treatment of growth failure in pediatric patients.
The persistent poverty initiative aims to fight the cumulative effects of persistent poverty on cancer outcomes.
UCB’s rozanolixizumab-noli is approved for treatment of generalized myasthenia gravis in certain adult patient groups.
Sanofi’s Open Innovation Portal is designed to promote community feedback and propose novel solutions to various problems in the healthcare landscape.